Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Endometrial cancer
Trial Type:  Treatment
Results 1-25 of 44 for your search:
Start Over
Paclitaxel and Carboplatin with or without Metformin Hydrochloride in Treating Patients with Stage III, IV, or Recurrent Endometrial Cancer
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GOG-0286B, NCI-2013-02284, NCT02065687
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Phase: Phase III
Type: Treatment
Age: Over 18
Trial IDs: ENGOT-EN2-DGCG/EORTC55102, NCI-2014-00983, 2010-023081-52, NCT01244789
Standard Radiation Therapy or Intensity-Modulated Pelvic Radiation Therapy in Treating Patients with Endometrial or Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 1203, NCI-2012-02001, CDR0000738944, NCT01672892
Study Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: AEZS -108-050, NCI-2013-01036, NCT01767155
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Aerosolized Aldesleukin in Treating Patients with Lung Metastases
Phase: Phase II, Phase I
Type: Treatment
Age: 12 and over
Trial IDs: 2010-0700, NCI-2012-00788, NCT01590069
Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCLR457X2101, NCI-2014-02051, NCT02189174
Radiation Therapy with or without Cisplatin in Treating Patients with Recurrent Endometrial Cancer
Phase: Phase II
Type: Treatment
Age: Not specified
Trial IDs: GOG-0238, NCI-2009-00603, CDR0000550975, NCT00492778
Levonorgestrel-Releasing Intrauterine System in Treating Patients with Complex Atypical Hyperplasia or Grade I Endometrial Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 2008-0094, NCI-2012-02118, NCT00788671
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients with High-Risk Endometrial Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 08-03-060, NCI-2013-01224, 07-062, NCI-2012-00458, NCT01041027
Carboplatin and Paclitaxel With or Without Trastuzumab in Treating Patients With HER2-Positive Stage III-IV or Recurrent Uterine Cancer
Phase: Phase II
Type: Treatment
Age: Not specified
Trial IDs: 1012007786, NCI-2013-00894, NCT01367002
PI3K Inhibitor BKM120 in Treating Patients With Refractory Advanced Solid Tumors That Have PIK3CA Mutations
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-211, NCI-2012-00257, NCT01501604
Pathology Intraoperative Consultation in Tailoring Surgery in Patients With Endometrial Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 11-GYN-130, NCI-2013-01938, NCT01512810
Alisertib in Treating Patients with Advanced or Metastatic Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A091102, NCI-2012-01991, CALGB-A091102, CDR0000737403, NCT01653028
FLT PET/CT in Planning Pelvic Radiation Therapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201204712, NCI-2013-00956, 04120117, NCT01717391
Everolimus, Letrozole, and Metformin Hydrochloride in Treating Patients with Advanced or Recurrent Endometrial Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2012-0543, NCI-2013-00960, RAD001CUS195T, NCT01797523
Trametinib with or without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GOG-0229O, NCI-2013-01659, NCT01935973
Dasatinib in Treating Patients with Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GOG-0283, NCI-2014-00209, NCT02059265
Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: VX-EC-2-2013, NCI-2014-02177, NCT02064725
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients with Stage IIIC-IV Uterine Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-02-058, NCI-2013-01226, NCT02112552
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GOG-3007, NCI-2015-00993, CRAD001CUS236T, NCT02228681
Stereotactic Radiosurgery in Treating Patients with Oligometastatic Disease
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-027, NCI-2014-01952, REN13120042, UPCI #10-027, NCT01345539
Stereotactic Radiosurgery in Treating Patients with Oligo-Recurrent Disease
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-028, NCI-2014-01953, REN13120040, UPCI# 10-028, NCT01345552
Start Over